<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H4FD1E9C330044DAD84756E99F29FF521" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>107 HR 9093 IH: Homeland Security Fentanyl Enforcement Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-09-30</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 9093</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220930">September 30, 2022</action-date><action-desc><sponsor name-id="H001077">Mr. Higgins of Louisiana</sponsor> (for himself, <cosponsor name-id="F000473">Mrs. Flores</cosponsor>, <cosponsor name-id="M001215">Mrs. Miller-Meeks</cosponsor>, <cosponsor name-id="M001211">Mrs. Miller of Illinois</cosponsor>, <cosponsor name-id="S000522">Mr. Smith of New Jersey</cosponsor>, <cosponsor name-id="C001126">Mr. Carey</cosponsor>, and <cosponsor name-id="B001291">Mr. Babin</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name>, and in addition to the Committees on <committee-name committee-id="HJU00">the Judiciary</committee-name>, and <committee-name committee-id="HIF00">Energy and Commerce</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to authorize Homeland Security Investigations to perform certain drug enforcement functions, and for other purposes.</official-title></form><legis-body id="H356355DD66AA4A6DB00F06E90213576F" style="OLC"><section id="HDB996BDE35704D6A9A2FB82B3D1796FC" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Homeland Security Fentanyl Enforcement Act</short-title></quote>. </text></section><section id="H7CAF45D674724C7A9AC191538B2EC9C9"><enum>2.</enum><header>Empowering Homeland Security Investigations to counter drug smuggling by transnational criminal organizations</header><subsection id="H9F6C8756F9D44947A0F8FB162B5AE3F0"><enum>(a)</enum><header>Powers of enforcement personnel</header><text display-inline="yes-display-inline">Section 508 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/878">21 U.S.C. 878</external-xref>) is amended by adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H80B5AC3A68664AE7A9D3FEB33E89D553"><subsection id="H279FDD0534004B308EE88F681C51D3CC"><enum>(c)</enum><text>Special Agents of Homeland Security Investigations and State, tribal, and local law enforcement officers designated by the Executive Associate Director for Homeland Security Investigations pursuant to section 401(i) of the Tariff Act of 1930 (<external-xref legal-doc="usc" parsable-cite="usc/19/1401">19 U.S.C. 1401(i)</external-xref>) shall have the powers and authorities described in subsection (a) for the enforcement of this Act, which shall be exercised in the performance of the Department of Homeland Security’s existing functions related to customs and criminal law enforcement under the Homeland Security Act of 2002 (<external-xref legal-doc="public-law" parsable-cite="pl/107/296">Public Law 107–296</external-xref>).</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H2F212484D82547AFB304F5B927ACB015"><enum>(b)</enum><header>Review and report on the deconfliction policies and practices of the Drug Enforcement Administration and Homeland Security Investigations regarding drug investigations</header><paragraph id="HB13E229C22D84E5C8462AFEF2C3AF784"><enum>(1)</enum><header>Review</header><text display-inline="yes-display-inline">The Comptroller General of the United States shall conduct a review of the deconfliction policies and practices between the Drug Enforcement Administration and Homeland Security Investigations that—</text><subparagraph id="H7649CC0CC86B46A9AF6CD5A3781D2140"><enum>(A)</enum><text>determines whether there is documented reciprocity between the Drug Enforcement Administration and Homeland Security Investigations in the policies and practices for deconfliction of investigations and operations carried out in accordance with the authorities set forth in the Controlled Substances Act and the Homeland Security Act of 2002;</text></subparagraph><subparagraph id="H1C54256C40864B88BF5CB8001BBE092A"><enum>(B)</enum><text>determines the number of investigations or operations initiated during the 1-year period beginning on the date of the enactment of this Act by Homeland Security Investigations or the Drug Enforcement Administration that did not adhere to the deconfliction policies and practices required under the agreement referred to in subparagraph (A); and</text></subparagraph><subparagraph id="HB7C5CF54A9BE4AF994F4DF751B51D24A"><enum>(C)</enum><text>determines the effect of the authorization under section 508(c) of the Controlled Substances Act, as added by subsection (a), on the deconfliction policies and practices of the Drug Enforcement Administration and Homeland Security Investigations, respectively.</text></subparagraph></paragraph><paragraph id="H6EA04004425D4A6CAEB6DA39DF40C408"><enum>(2)</enum><header>Report</header><text>Not later than 18 months after the date of the enactment of this Act, the Comptroller General shall submit a report to the <committee-name committee-id="SSGA00">Committee on Homeland Security and Governmental Affairs of the Senate</committee-name>, the <committee-name committee-id="SSJU00">Committee on the Judiciary of the Senate</committee-name>, the <committee-name committee-id="">Committee on Homeland Security of the House of Representatives</committee-name>, and the <committee-name committee-id="">Committee on the Judiciary of the House of Representatives</committee-name> that contains—</text><subparagraph id="H5D1D6136FB8E47749EBC21EFBF8F5F69"><enum>(A)</enum><text>a detailed summary of the findings of the review conducted pursuant to paragraph (1); and</text></subparagraph><subparagraph id="H15254FD307944852BF8CF3A42942AADF"><enum>(B)</enum><text>any recommendations to modernize deconfliction policies and procedures to ensure reciprocity between the Drug Enforcement Administration and Homeland Security Investigations regarding investigative functions related to controlled substances, transnational criminal organizations, or other areas where respective jurisdictions and authorities may overlap.</text></subparagraph></paragraph></subsection></section></legis-body></bill> 

